Observational studyThe Journal of investigative dermatology2018

Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Ireny Y K Iskandar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.